The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease.
نویسندگان
چکیده
The first clinical trials of stem cell (SC) treatment for cardiac disease in humans, using autologous bone marrow cell transplantation in patients with severe chronic heart failure (HF), were reported in 2002 (using the intracoronary injection route) and in 2003 (using the intramyocardial injection route). Since those initial reports, numerous additional clinical SC trials have been conducted in the treatment of cardiac disease, with approximately 30 trials under way in the United States in 2012. In addition to bone marrow–derived hematopoietic SCs, subsequent clinical trials have used mesenchymal SCs, endothelial progenitor cells, skeletal myoblasts, induced pluripotent SCs (and derivatives), and cardiac-resident SCs. Currently, the 3 main indications for SC treatment in patients with heart disease are chronic ischemic HF, acute myocardial infarction, and idiopathic dilated cardiomyopathy. On the basis of trials over the past decade, “cell herapy may transform the treatment of acute and chronic eart disease, with an anticipated impact rivaling the results
منابع مشابه
Challenges for treatment of cardiovascular diseases based on stem cells
Introduction: Cardiovascular diseases (CVD) are the primary cause of death worldwide, and the development of scar tissue in myocardium and also the irreversible destruction of cardiomyocytes are the main factors in their development. There are still limitations in medical treatment of CVD, despite the advances in the field of drug therapy and surgery for CVD. In recent years, research on stem c...
متن کاملO19: Advances in the Treatment and Limitations of Cell Therapy in Neurodegenerative Diseases
Neurodegenerative diseases are the hereditary and sporadic diseases which are characterized by progressive neuronal loss of the nervous system and are emerging as the leading cause of death, disabilities, and a socioeconomic burden due to an increase in life expectancy. There are many neurodegenerative diseases including Alzheimer’s disease, Parkinson’s, disease, amyotrophic lateral...
متن کاملRecent Technological Advances in Hepatogenic Differentiation of Stem Cells Relevant to Treatment of Liver Diseases
Liver failure, in an acute or chronic form, is a growing health problem ranking as one of the leading causes of death worldwide. Inborn errors of metabolism characterized by defects in hepatic enzymes or other proteins with metabolic functions, such as receptors or transporters accompanied with environmental factors involve etiology and presentation of liver failure. Currently, the only establi...
متن کاملCell Therapy in Cardiovascular Disease
Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...
متن کاملOnm-19: The Role of Cord Blood Preservationin Cell Therapy
s:3604:"During pregnancy, the placenta delivers "cord blood" to the baby through the umbilical cord serving as a lifeline of nourishment from the mother to baby. At birth, "cord blood" remains in the umbilical cord and placenta and until recently, had typically been discarded. The tragedy of this practice is that "cord blood" contains very special cells called "stem cells". Recent advances in m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The American journal of cardiology
دوره 110 6 شماره
صفحات -
تاریخ انتشار 2012